Raymond James & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $166M | Buy |
|
|||||
|
2024
Q2 | $132M | Sell |
|
|||||
|
2024
Q1 | $183M | Buy |
|
|||||
|
2023
Q4 | $126M | Sell |
|
|||||
|
2023
Q3 | $174M | Sell |
|
|||||
|
2023
Q2 | $195M | Buy |
|
|||||
|
2023
Q1 | $196M | Buy |
|
|||||
|
2022
Q4 | $200M | Sell |
|
|||||
|
2022
Q3 | $217M | Sell |
|
|||||
|
2022
Q2 | $251M | Sell |
|
|||||
|
2022
Q1 | $275M | Buy |
|
|||||
|
2021
Q4 | $222M | Buy |
|
|||||
|
2021
Q3 | $198M | Buy |
|
|||||
|
2021
Q2 | $223M | Buy |
|
|||||
|
2021
Q1 | $205M | Sell |
|
|||||
|
2020
Q4 | $222M | Buy |
|
|||||
|
2020
Q3 | $200M | Buy |
|
|||||
|
2020
Q2 | $180M | Buy |
|
|||||
|
2020
Q1 | $144M | Buy |
|
|||||
|
2019
Q4 | $165M | Buy |
|
|||||
|
2019
Q3 | $105M | Buy |
|
|||||
|
2019
Q2 | $80.6M | Buy |
|
|||||
|
2019
Q1 | $82.4M | Buy |
|
|||||
|
2018
Q4 | $55.8M | Sell |
|
|||||
|
2018
Q3 | $69.9M | Buy |
|
|||||
|
2018
Q2 | $59.9M | Sell |
|
|||||
|
2018
Q1 | $75.4M | Buy |
|
|||||
|
2017
Q4 | $69.2M | Sell |
|
|||||
|
2017
Q3 | $73.7M | Sell |
|
|||||
|
2017
Q2 | $65.2M | Sell |
|
|||||
|
2017
Q1 | $65.2M | Buy |
|
|||||
|
2016
Q4 | $70M | Sell |
|
|||||
|
2016
Q3 | $118M | Buy |
|
|||||
|
2016
Q2 | $151M | Buy |
|
|||||
|
2016
Q1 | $118M | Buy |
|
|||||
|
2015
Q4 | $118M | Buy |
|
|||||
|
2015
Q3 | $87.5M | Buy |
|
|||||
|
2015
Q2 | $87.4M | Buy |
|
|||||
|
2015
Q1 | $55.9M | Buy |
|
|||||
|
2014
Q4 | $48.2M | Sell |
|
|||||
|
2014
Q3 | $51.2M | Buy |
|
|||||
|
2014
Q2 | $41.1M | Sell |
|
|||||
|
2014
Q1 | $44M | Sell |
|
|||||
|
2013
Q4 | $45.5M | Sell |
|
|||||
|
2013
Q3 | $41.4M | Sell |
|
|||||
|
2013
Q2 | $46.3M | Buy |
|